Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Selby

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|May 1, 1987
Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapyP J Selby, N Lopes, J Mundy, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 17, 2005
Development and evaluation of an instrument to assess social difficulties in routine oncology practiceE P Wright, M Kiely, C Johnston, et al.
Cytokine|November 13, 1998
Interleukins 4 and 13 upregulate expression of cd44 in human colonic epithelial cell linesL K Trejdosiewicz, R Morton, Y Yang, et al.
Cancer Immunology, Immunotherapy : CII|August 14, 2001
Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor moleculeA J Stanley, M J Gough, R E Banks, et al.
Postgraduate Medical Journal|June 1, 1987
Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromesJ L Mansi, P J Selby, R L Carter, et al.
Psycho-Oncology|December 15, 2005
Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression ScaleA B Smith, E P Wright, R Rush, et al.
The Journal of Urology|January 13, 2006
Novel urothelium specific gene expression identified by differential display reverse transcriptase-polymerase chain reactionG D Hall, B Smith, R J Weeks, et al.
Cancer Research|March 14, 2001
Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urotheliumB A Smith, W J Kennedy, P Harnden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
The prevalence and outcomes of frailty in older cancer patients: a systematic reviewC Handforth, A Clegg, C Young, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
The combination of melphalan with prednisolone. Anti-tumor effect and normal tissue toxicity in laboratory systemsP J Selby, J L Millar, T A Phelps, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|May 1, 1987
Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapyP J Selby, N Lopes, J Mundy, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 17, 2005
Development and evaluation of an instrument to assess social difficulties in routine oncology practiceE P Wright, M Kiely, C Johnston, et al.
Cytokine|November 13, 1998
Interleukins 4 and 13 upregulate expression of cd44 in human colonic epithelial cell linesL K Trejdosiewicz, R Morton, Y Yang, et al.
Cancer Immunology, Immunotherapy : CII|August 14, 2001
Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor moleculeA J Stanley, M J Gough, R E Banks, et al.
Postgraduate Medical Journal|June 1, 1987
Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromesJ L Mansi, P J Selby, R L Carter, et al.
Psycho-Oncology|December 15, 2005
Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression ScaleA B Smith, E P Wright, R Rush, et al.
The Journal of Urology|January 13, 2006
Novel urothelium specific gene expression identified by differential display reverse transcriptase-polymerase chain reactionG D Hall, B Smith, R J Weeks, et al.
Cancer Research|March 14, 2001
Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urotheliumB A Smith, W J Kennedy, P Harnden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
The prevalence and outcomes of frailty in older cancer patients: a systematic reviewC Handforth, A Clegg, C Young, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
The combination of melphalan with prednisolone. Anti-tumor effect and normal tissue toxicity in laboratory systemsP J Selby, J L Millar, T A Phelps, et al.
Pageof 11